ModicaP.S.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-10-19
Share capital
600 000,00 PLN
Activity description

Modica is a company that provides a modular plug-and-play system for bio-manufacturers to develop and scale up new compounds in the biotech and healthcare industries. Their offerings include the Modica Smart Grid for media supply and control, Modica Smart Modules for monitoring bioprocess variables, and the Modica Control Platform for real-time data management. These solutions aim to reduce production costs and time while improving efficiency and flexibility in bioprocessing.

Registered address
ul. Żurawia 45, 00-680 Warszawa, Poland
Website
modica.bioWebsite active
Email
Email warning
Social media
Electronic delivery address
AE:PL-90919-45791-DFSUI-17

Financials

The financial statement for 2024 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue
This companyUSD 103.40kMedianUSD 38.54kAverageUSD 2.32m
Net profit
This companyUSD -5.23kMedianUSD -1.56kAverageUSD -88.44k
Operating costs
This companyUSD 107.39kMedianUSD 56.03kAverageUSD 2.29m
Assets
This companyUSD 22.50kMedianUSD 119.99kAverageUSD 2.73m

Bank accounts

Registered as a VAT taxpayer on 2023-04-27. Active

  • mBank
    06 1140 1140 0000 2352 6700 1003
  • mBank
    33 1140 1140 0000 2352 6700 1002
  • mBank
    60 1140 1140 0000 2352 6700 1001

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
Aid for research and development projects: industrial research
$959.0K
Aid for research and development projects: experimental development
$353.5K

European Funds

ProjectEU co-financing
Realizacja prac B+R w celu opracowania innowacyjnego, adaptacyjnego, cyfrowego bliźniaka (Adaptive Digital Twin - ADT) do modelowania procesów biotechnologicznych z wykorzystaniem modularnych komponentów sprzętowych bioreaktora, umożliwiającego efektywne skalowanie bioprocesów i pracę w trybie niemal ciągłym
$1.6M

Tenders

No recorded participation in tenders.

Authorized Representatives

Wojciech Janik – Management Board Member
Łukasz Jerzy Paciorkowski – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Beneficial owners

Person

Competitors

Name
DigitmedS.A.
BiottsS.A.
MedisensonicS.A.
Medicofarma BiotechS.A.
XORsp. z o.o.
Microbe Plussp. z o.o.
ATER Netsp. z o.o.
Green Cenergysp. z o.o.
CadenasP.S.A.
Bio2materialssp. z o.o.

FAQ

Last updated: 2026-04-02